In the BioHarmony Drug Report Database
Molindone
Moban (molindone) is a small molecule pharmaceutical. Molindone was first approved as Moban on 1982-01-01. It is used to treat psychotic disorders, schizophrenia, and schizophrenia spectrum and other psychotic disorders in the USA. The pharmaceutical is active against 5-hydroxytryptamine receptor 2A. In addition, it is known to target histamine H1 receptor.
Trade Name
|
Moban |
|---|---|
Common Name
|
molindone |
ChEMBL ID
|
CHEMBL460 |
Indication
|
psychotic disorders, schizophrenia, schizophrenia spectrum and other psychotic disorders |
Drug Class
|
Typical antipsychotic |
Image (chem structure or protein)